- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
ABTT34
SAO
Week ended 07 Aug 2026
Weekly Investor Report
Abbott Laboratories · Healthcare · Medical Devices
Latest close
45.50 BRL
1.5%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 5.9% above the Trend Line and sits at 43.4% of its 52-week range. The latest completed week returned 1.5%, after a 13.5% four-week move. The latest news-sentiment score is 67/100. Near-term considerations: volume confirmation is below normal.
Setup score
39
out of 100
Latest Close
45.50 BRL
7 Aug 2026
1W Return
1.5%
latest completed week
4W Return
13.5%
short-term follow-through
12W Return
27.1%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.5%
Latest completed week; four-week move 13.5%.
Indicator stack
0/79
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
67/100
16 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 5.9% above the Trend Line and sits at 43.4% of its 52-week range. The latest completed week returned 1.5%, after a 13.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1812-week average 0.06
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.18Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 13.5% over four weeks, 27.1% over 12 weeks, and -24.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.00Latest activity-pressure read.
Pressure change142.6%Four-week change in activity pressure.
Leadership-12.25Latest relative-leadership reading.
RS change56.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment67/100
Weighted news tone is positive across 16 relevant articles.
6 positive · 9 neutral · 1 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-25.6%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+9.1%Week of 5 Jun.
Worst week-8.1%Week of 8 May.
Latest week+1.5%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains10
Flat weeks0
Modest losses6
Sharp losses6
Recent vol4.1%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew2.4% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorBR Healthcare
4-week rank5 / 82
Group average-0.7%
Trend breadth35.4%
Trend35.4%active weekly trend signals
MD65.9%positive activity pressure
RS46.3%positive relative leadership
Four-week leaders
IndustryBR Medical Devices
4-week rank1 / 7
Group average4.8%
Trend breadth28.6%
Trend28.6%active weekly trend signals
MD85.7%positive activity pressure
RS14.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape30/100
Trend, activity pressure, participation, and risk combine to a 30/100 tape read.
Indicator analysis22/100Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.
Activity pressure 0.18; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment67/100Weighted news tone is positive across 16 relevant articles.
Arrow Exploration confirms four zones at Icaco 3, opens up ~10 new drilling locations Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 45.50 BRL | 1.5% | 42.95 BRL | 50.19 BRL | 1.00 | -12.25 | 778 | Off |
| 31 Jul 2026 | 44.81 BRL | 2.6% | 43.29 BRL | 50.16 BRL | 0.91 | -17.20 | 1.7K | Off |
| 24 Jul 2026 | 43.67 BRL | 2.9% | 43.66 BRL | 50.15 BRL | 0.83 | -18.45 | 1.0K | Off |
| 17 Jul 2026 | 42.44 BRL | 5.9% | 44.10 BRL | 50.14 BRL | 0.72 | -21.47 | 6.7K | Off |
| 10 Jul 2026 | 40.09 BRL | -3.4% | 44.57 BRL | 50.15 BRL | 0.41 | -28.38 | 933 | Off |
| 3 Jul 2026 | 41.51 BRL | 2.6% | 45.09 BRL | 50.16 BRL | 0.07 | -25.29 | 271 | Off |
| 26 Jun 2026 | 40.45 BRL | 6.4% | 45.58 BRL | 50.16 BRL | -0.13 | -27.59 | 503 | Off |
| 19 Jun 2026 | 38.00 BRL | 3.7% | 46.14 BRL | 50.17 BRL | -0.56 | -30.92 | 3 | Off |
| 12 Jun 2026 | 36.63 BRL | -7.0% | 46.78 BRL | 50.19 BRL | -0.79 | -35.21 | 460 | Off |
| 5 Jun 2026 | 39.41 BRL | 9.1% | 47.46 BRL | 50.22 BRL | -0.91 | -30.40 | 8.4K | Off |
| 29 May 2026 | 36.12 BRL | -1.1% | 47.98 BRL | 50.22 BRL | -1.17 | -38.72 | 894 | Off |
| 22 May 2026 | 36.54 BRL | 2.1% | 48.61 BRL | 50.25 BRL | -1.13 | -39.71 | 4.2K | Off |
| 15 May 2026 | 35.80 BRL | 4.1% | 49.27 BRL | 50.28 BRL | -1.23 | -42.05 | 881 | Off |
| 8 May 2026 | 34.40 BRL | -8.1% | 49.99 BRL | 50.33 BRL | -1.23 | -47.10 | 8.6K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.